百洋医药ZAP-X火星舟亮相国际放疗盛会ASTRO，展示脑组织保护新成果

Core Insights - The 67th American Society for Radiation Oncology (ASTRO) annual meeting was held in San Francisco, attracting over 10,000 radiation oncology experts and scholars from around the world [1] - John R. Adler, founder and CEO of ZAP Surgical, presented the inception and technological philosophy behind ZAP-X, garnering significant interest from attendees [1] - Despite the long-standing application of Stereotactic Radiosurgery (SRS), nearly 80% of patients still lack access to high-quality treatment due to cost, facility, and technical issues, particularly in the treatment of benign and malignant brain tumors [1]